Canon’s Optical Coherence Tomography Device Grabs FDA Clearance

September 19, 2019

The FDA has granted 510(k) clearance for Canon’s Xephilio OCT-A1, an optical coherence tomography device that is used to create high resolution images of a patient’s retina.

The non-invasive device is indicated for in-vivo imaging and measurement of the retain, optical disc and retinal nerve fiber layer, and can help clinicians diagnose and manage retinal diseases.

The Xephilio OCT-A1 works with a computer, LCD monitor and Canon’s RX Capture software and is designed for easy use, preserving the scan position and protocol for each patient to eliminate the need for manual adjustment.

View today's stories